Home
Learn More
Release Features
Success Stories
Contact Us
Search Archives
PRWeb Direct
Submit Release
May 16, 2008
 
Industry Categories  
News by Country  
News by MSA  
Todays News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
 
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Web site.
 
Close Move
All Press Releases for April 11, 2006 Subscribe to this News Feed      
 

AVONEX.com Launches Redesigned Multiple Sclerosis (MS) Web Site

Catalyst on-line Inc., a full service Interactive Marketing agency, is excited to announce the re-launch of AVONEX.com. AVONEX is the number one prescribed MS Treatment in the U.S. today.

Newton, MA (PRWEB) April 11, 2006 -- Catalyst on-line Inc. is excited to announce the re-launch of Biogen Idec product website, AVONEX.com. The new website, which launched on March 30th, features a new look and feel, streamlined navigation, and a renewed focus on meeting the health literacy needs of patients living with multiple sclerosis (MS).

Health literacy is defined as the ability to read, understand and act on health information. Nearly half of all American adults — 90 million people — have difficulty understanding health information. There is no value to a website if the user is unable to understand the information within, and know what actions are necessary to take charge of their health.

To better meet the health literacy needs of the site visitors, the new AVONEX.com features:

  • Restructured site content that is more focused on user goals and priorities
  • A reorganization of site information to increase overall usability
  • Site content written in patient friendly language
  • Stronger calls to action

Since its release in the U.S. market over ten years ago, many people living with multiple sclerosis (MS) have continued to choose and trust AVONEX (Interferon beta-1a) as their preferred MS treatment, making AVONEX the number one prescribed MS treatment in the U.S. today.

Catalyst on-line Inc., a women owned business, is a full service Interactive Marketing agency, offering industry-leading online marketing capabilities including strategy consulting, website development, and search engine optimization. We combined our online expertise with our specialization in health care to help our customers achieve and sustain a competitive advantage in all markets. Catalyst on-line has developed effective, successful online strategies and campaigns for many of the top pharmaceutical and biotechnology companies, including Pfizer, Novartis, and Biogen Idec. If you would like more information about Catalyst on-line Inc. or any of our services please visit our website at www.catline.com or call us at 617-244-4697.

Please visit www.avonex.com">www.avonex.com and check out the new site.

# # #

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/Q3Jhcy1QaWdnLU1hZ24tWmV0YS1IYWxmLVplcm8=

Technorati Tags

Bookmark -  Del.icio.us | Digg | Furl It | Spurl | RawSugar | Simpy | Shadows | Blink It | My Web



OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareIt

Share The News

Submit this press release easily to any of these major bookmarking and social media sites.

CONTACT INFORMATION
Heather Frahm
Catalyst On-line
617-244-5148
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your login.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these releases. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright